Wells Fargo & Company Bio Restorative Therapies, Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Bio Restorative Therapies, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 965 shares of BRTX stock, worth $1,505. This represents 0.0% of its overall portfolio holdings.
Number of Shares
965
Previous 1,480
34.8%
Holding current value
$1,505
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding BRTX
# of Institutions
14Shares Held
249KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA52.3KShares$81,6450.0% of portfolio
-
Stone X Group Inc.50.1KShares$78,1560.01% of portfolio
-
Wealth Alliance Mellville, NY40KShares$62,4000.01% of portfolio
-
Ubs Group Ag27.8KShares$43,3880.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.5KShares$31,9360.0% of portfolio
About BioRestorative Therapies, Inc.
- Ticker BRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 3,650,030
- Market Cap $5.69M
- Description
- BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtx...